• Contributed to a 10-fold increase in the company's annual revenue by evaluating market trends and assisting in supply chain management.• Assessed market conditions to identify key products and raised their prices, leading to a 125-fold YOY sales volume increase and a 410-fold revenue increase in the HP channel.• Strategically identified key products and increased their prices, resulting in a 38.9% YOY sales volume increase and a 76.7% revenue increase in the GP channel.• Successfully listed 3 products in Medical Centers.• Awarded 13 SKUs in Arm-forced hospitals tender (2022-2024).• Supported the RA team with patent affairs and expedited the TFDA GMP inspection schedule by 6 months.• Supported the operation of the company with IT and legal issues.• Assisted in acquiring talents for the company.

• Promoted to hire and manage marketing teams of 4 product managers responsible for developing omnichannel marketing and A&P strategies for overall products. • Designed pricing strategy for new product launches. Improved company profitability by driving products to high-margin models.• Collaborated with cross-functional units, including sales, BD, finance, and legal teams, to prepare new product launches.• Maintained relationships with KOLs to identify prescription trends and corresponding marketing strategies.• Developed a partnership with agencies to sell OTC products on e-commerce platforms.

• Promoted to lead a marketing team of 2 product managers to manage varied product portfolios, including cardiology, endocrinology, urology, gastroenterology, nephrology, neurology, and pulmonology. • Designed pricing strategies and implemented a campaign program in HP and GP channels.• Communicated with NMCs to enhance alignment with brand strategies by developing and implementing strategic marketing plans. • Provided sales budgets to monitor actual sales and support supply chain management.

• Driven the market share of Telsar, a generic version of Telmisartan, over that of Micardis, the brand-name drug, in the GP channel by converting scientific data into product selling slogans. • Provided continuous market intelligence as a medical information resource and logistic support for the symposium at congresses.

• Promoted to product manager in 2017 due to consistent target achievement of over 100%.• Achieved 112% territory target in 2016 by developed relationships with more than 50 physicians and stakeholders.• Achieved 102% Q4 territory target in 2015.

• Responsible for the sales of laboratory equipment and reagents in the areas of Academia Sinica, Taipei Veterans General Hospital, and Yang-Ming University.

• Established the company's ISO 17025 and 13485 SOPs and successfully obtained ISO certification for the company.• Developed and improved cervical cancer detection reagents.

• Assisted the professor in procuring laboratory equipment and reagents.

• Established an embryo stem cell for nervous necrosis virus production.